Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 4

Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease

Total article views   HTML views PDF downloads Totals
6,041 Dovepress* 6,041+ 1,672 7,713
Totals 6,041 1,672 7,713
*Since 8 August 2008
+Since July 2016

View citations on Google Scholar